Atherectomy Devices Market - Global Forecast 2025-2032

The atherectomy devices market is experiencing significant evolution, driven by advanced technologies, emerging clinical requirements, and changing demands across global healthcare systems. Senior executives require focused, accurate intelligence to inform high-stakes decisions and enhance performance in this dynamic sector.

Market Snapshot: Atherectomy Devices Market Size and Growth

The atherectomy devices market expanded from USD 1.03 billion in 2024 to USD 1.12 billion in 2025, with upward projections to USD 2.02 billion by 2032, showing a compound annual growth rate (CAGR) of 8.69%. This robust growth is propelled by growing adoption of minimally invasive techniques, continual improvement in device precision, and a strong focus on optimizing patient results. Ongoing development of device functionalities and adoption of advanced clinical protocols are reinforcing atherectomy's status as a pivotal approach for vascular interventions worldwide.

Scope & Segmentation of the Atherectomy Devices Market

• Device Types: Directional, laser, orbital, and rotational devices serve a wide spectrum of interventional needs, supporting both standard and complex vascular cases and enabling tailored solutions for varied anatomical challenges.
• Clinical Applications: Atherectomy technologies address both coronary and peripheral interventions, facilitating effective treatment for arteries such as carotid, popliteal, and superficial femoral, thus enhancing the versatility of minimally invasive care.
• End Users: Utilization is broad, covering hospitals, ambulatory surgical centers, vascular clinics, and procedural labs, making the technology accessible to diverse healthcare providers and supporting high adoption even in specialized centers.
• Mode Types: Both continuous and intermittent operation settings are available, providing therapy flexibility and allowing physicians to adapt device use to individual procedural requirements, which supports outcome optimization.
• Regions Covered: Adoption is robust across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Local priorities and healthcare infrastructure adaptations guide procurement decisions and shape regional device configurations.
• Companies Analyzed: The market assessment includes major firms such as Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., AngioDynamics, Inc., Terumo Corporation, Becton, Dickinson and Company, OrbusNeich Medical Company Limited, and ConMed Corporation, each exhibiting distinct differentiation strategies and ongoing innovation efforts.

Key Takeaways for Senior Decision-Makers

• Device manufacturers are investing in enhancements like advanced tip geometry, integrated imaging, and digital connectivity to improve procedural accuracy and support clinical decision-making.
• The use of atherectomy in both coronary and peripheral procedures marks a strategic shift towards safer, more versatile patient management options across interventional practices.
• Procurement strategies are evolving, driven by the need to demonstrate clinical efficacy and operational efficiency, as reimbursement landscapes increasingly favor long-term, value-based solutions.
• Collaborations with contract manufacturers and digital health partners are fostering faster product innovation cycles and enabling broader market penetration for key stakeholders.
• Customization of operational modes to address varying procedural demands highlights the importance of clinician training and ongoing multidisciplinary collaboration to maximize patient outcomes within healthcare settings.

Tariff Impact on Atherectomy Device Supply Chains

Upcoming United States tariffs in 2025 are set to increase production costs for atherectomy devices by impacting imports of essential materials, including catheters and optical fibers. Leading organizations are adjusting to this shift by reevaluating pricing frameworks, pursuing supplier diversification, and investing in regional manufacturing efficiency, including automation. Companies prioritizing robust, local supply chains are likely to remain agile amid regulatory disruptions and continue to deliver consistent innovation and market presence.

Research Methodology & Data Sources

This market analysis is grounded in systematic secondary research from regulatory filings, peer-reviewed clinical literature, and established outcome registries. Primary findings are supported by confidential interviews with physicians, procurement leaders, and executive stakeholders to ensure findings are balanced and unbiased.

Why This Report Matters for Executives

• Access a detailed, actionable overview of segmentation, technology implementation, and shifting regional priorities to inform strategic decisions.
• Understand the ways regulatory and reimbursement developments shape organizational outcomes and commercial direction within the atherectomy devices field.
• Gain insights into the key players, technological trends, and collaboration prospects that are vital for long-term competitiveness and product innovation.

Conclusion

This report empowers senior leaders with focused, data-driven insights into clinical, technical, and regional market dynamics, supporting informed navigation of sector complexities and effective strategies for advancing care and growth objectives.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.